Compare
Sintx Technologies, Inc. vs RenovoRx, Inc. vs Flyte Aviation, Inc. vs Harvard Apparatus Regenerative Technology, Inc.
| Latest fiscal year | Sintx Technologies, Inc. SINT | RenovoRx, Inc. RNXT | Flyte Aviation, Inc. VJET | Harvard Apparatus Regenerative Technology, Inc. HRGN |
|---|---|---|---|---|
| Year ended | 2025-12-31 | 2025-12-31 | 2025-12-31 | 2025-12-31 |
| Revenue | $1.02M | $1.12M | $819.0K | $704.0K |
| Revenue growth (YoY) | -64.7% | n/m | +95.0% | +63.7% |
| Gross margin | 45.3% | 70.9% | 92.3% | n/a |
| Operating margin | n/m | n/m | n/m | -982.2% |
| Net margin | n/m | -994.5% | n/m | -975.7% |
| Net income | -$10.36M | -$11.17M | -$17.18M | -$6.87M |
| EPS (Diluted) | -$6.16 | -$0.32 | n/a | n/a |
| Operating cash flow | -$8.57M | -$10.97M | -$8.30M | -$3.83M |
| Free cash flow | -$8.76M | -$10.97M | -$8.31M | n/a |
| Cash & equivalents | $4.14M | $7.02M | $88.0K | $1.35M |
| Total assets | $9.51M | $8.10M | $15.86M | $2.68M |
| Total liabilities | $6.58M | $2.67M | $9.21M | $1.62M |
| Shareholders' equity | $2.93M | $5.42M | $7.05M | $1.06M |
| Return on year-end equity | -353.8% | -206.0% | -243.6% | -649.9% |
| Shares outstanding | 3.97M | 36.61M | 1.74M | 17.58M |
Revenue, most recent five fiscal years
| Fiscal year | Sintx Technologies, Inc. | RenovoRx, Inc. | Flyte Aviation, Inc. | Harvard Apparatus Regenerative Technology, Inc. |
|---|---|---|---|---|
| Latest | $1.02M Ended 2025-12-31 | $1.12M Ended 2025-12-31 | $819.0K Ended 2025-12-31 | $704.0K Ended 2025-12-31 |
| 1 year earlier | $2.89M Ended 2024-12-31 | $43.0K Ended 2024-12-31 | $420.0K Ended 2024-12-31 | $430.0K Ended 2024-12-31 |
| 2 years earlier | $2.63M Ended 2023-12-31 | n/a | $442.0K Ended 2023-12-31 | $103.0K Ended 2023-12-31 |
| 3 years earlier | $1.56M Ended 2022-12-31 | n/a | $14.0K Ended 2022-12-31 | n/a |
| 4 years earlier | $606.0K Ended 2021-12-31 | n/a | $22.0K Ended 2021-12-31 | n/a |